May 12, 2008
Drug safety: Isotretinoin makers to comply with new FDA monitoring plan
“While the details of the REMS are still being worked out, we do not believe that the approved REMS will be substantially different from the existing risk management plans unless new safety information suggests that the existing plan is not working”
Isotretinoin manufacturers waiting to see if iPLEDGE will meet FDA's new safety guidelines National report - Manufacturers of isotretinoin are awaiting more information to determine whether iPLEDGE - the ... via Dermatology Times
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Abilify plus an antidepressant for mood disorders (from Mar '06) | 21 hr | Patti | 113 |
| Paranoid schizophrenia? Please help!! | Jul 21 | Techzilla | 11 |
| User One with nature still here? | Jul 21 | hyper | 1 |
| People with Schizophrenia Don't Stay on Meds (from Jul '07) | Jul 18 | happy | 59 |
| helpful, kinda (from Sep '07) | Jul 18 | Jim Beam | 9 |
| hallucinations | Jul 17 | Jim Beam | 3 |
| Small Survey - How many voices do you hear in a... (from Mar '07) | Jul 17 | Jim Beam | 13 |
Most Popular
